NADER JAVAN: Open Payments
NPI 1215298823 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$959 in 57 payments from 13 companies in 2025. Trend: 2023 $1,431 · 2024 $1,421 · 2025 $959
Food & beverage: $959
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 23 | $257 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $104 |
| Abbott Laboratories | 4 | $89 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $39 |
| Inspire Medical Systems, Inc. | 1 | $38 |
Products named: Kerendia, MOUNJARO, JARDIANCE, CAPLYTA, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, XIFAXAN, ZENPEP.
Industry payments across OH — which companies pay providers there.
